Piramal Pharma reports consolidated net loss of Rs 90 crore in Q3 ...Middle East

Piramal Pharma on Thursday reported a net loss of Rs 90 crore on a consolidated basis for the third quarter ended December 31, 2022. The Mumbai-based company had reported a net profit of Rs 163 crore in the October-December quarter of last fiscal. Revenue from operations stood at Rs 1,716 crore for the third quarter, while the same was at Rs 1,539 crore in the year-ago period. The company said the third quarter results were not comparable to the same period last year as the NCLT in August 12, 2022 approved the composite scheme of demerger of the pharma business from Piramal Enterprises Ltd (PEL) into Piramal Pharma Ltd. The NCLT also approved amalgamation of Piramal Pharma's wholly-owned sub

Hence then, the article about piramal pharma reports consolidated net loss of rs 90 crore in q3 was published today ( Thursday 09/02/2023 - 12:48 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Piramal Pharma reports consolidated net loss of Rs 90 crore in Q3 )

Also on site :

• Hivemind Capital and CPIC Investment Management Announce Strategic Partnership to Establish $500 Million Real-World Asset Tokenization Fund
• Lee Kum Kee zahajuje ve spolupráci s UNESCO „Forever Flavors Project" s cílem vybudovat světový archiv kulinářských vzpomínek
• Low Prices, Strong Demand, and the Cracks in the Oil Glut Story